FDANonrulemakingFDA-2018-D-2281
Who commented on this docket
Innovative Approaches for Nonprescription Drug Products; Draft Guidance for Industry; Availability
7 organizations filed 7 public comments on Innovative Approaches for Nonprescription Drug Products; Draft Guidance for Industry; Availability, at the Food and Drug Administration. The comment window closed 2871d ago.
Organizations
7
Comments
7
RIN
—
Comment window
closed 2871d ago
Commenters (7)
- American Association of Nurse Practitionerstrade assoc.1 filing · confidence 85%
- American Pharmacists Association (APhA)trade assoc.1 filing · confidence 97%
- Biograph Inc.unverified attribution1 filing · confidence 70%
- Consumer Healthcare Products Associationtrade assoc.1 filing · confidence 97%
- National Association of Chain Drug Storestrade assoc.1 filing · confidence 97%
- National Community Pharmacists Associationtrade assoc.1 filing · confidence 97%
- Pharmaceutical Care Management Associationtrade assoc.1 filing · confidence 85%
Attribution is name-based and imperfect. regulations.gov data is public record.